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to be adherent than females (p = 0.05). CONCLUSIONS: American Diabetes Associa-
tion guidelines recommend statin therapy in every diabetes patients of age 40 years 
and above, regardless of their low-density lipoprotein level. Low adherence can result 
in the development of cardiovascular diseases, which can lead to increase in outpatient 
and emergency room visits and hence, increase in the health care costs. Adherence to 
statins was suboptimal among this study population. This presents an increased risk 
of developing cardiovascular diseases, which can lead to increases in the health care 
costs for this self-insured university.
PDB47
IMPROVING OUTCOMES AND PRODUCTIVITY FOR EMPLOYEES WITH 
DIABETES
Pinto S1, Partha G1, Ferrell M1, Coehrs B2, Riepenhoff C2
1University of Toledo, Toledo, OH, USA, 2Pharmacy Counter, Toledo, OH, USA
OBJECTIVES: To examine the effect of a community pharmacy based medication 
therapy management program (MTM) on patient outcomes over one year. METHODS: 
A one year, pre-post longitudinal study. Patients served as their own controls. Com-
munity pharmacists provided MTM services to the City of Toledo employees and their 
dependents with diabetes. Employees were seen every 3 months at one of seven par-
ticipating pharmacy sites. Participants received a 3 month supply of medications at 
the cost of one co-pay as an incentive. Data collected: quality of life scores (SF-36), 
self-reported adherence (Modiﬁed Morisky scale of 1–5, 1 being always adherent and 
5 being never adherent), number of sick days, and patient satisfaction with services 
(Likert scale of 1–5, 1 being highly unsatisﬁed and 5 being highly satisﬁed). Data was 
analyzed using SPSS v 16.0 for one year using descriptive statistics and Friedman tests. 
RESULTS: One hundred one employees enrolled at baseline. Patients had improved 
scores on physical functioning, role physical, bodily pain, and social functioning. The 
physical component summary remained roughly the same. Mental component scores 
decreased, but not signiﬁcantly. Self-reported adherence improved signiﬁcantly from 
3.83 to 2.68 (p < 0.005) over 12 months. There was a decrease in the use of sick days 
from 1.13 ± 5.32 at baseline to 0.09 ± 0.39(p = 0.368) at the end of the study. Patients 
who reported using sick days at baseline on average reported less use of sick days 
over one year. Overall patient satisfaction signiﬁcantly increased from 3.26 to 4.52 
(p < 0.001) over 12 months. Experience with the pharmacist and experience with 
pharmacy services were the highest rated items. CONCLUSIONS: Improved quality 
of life and adherence can help increase productivity of employees and can help reduce 
costs for employers by reducing disease-related missed days of work. Employers 
looking to save costs and improve productivity can utilize the services provided by 
pharmacists.
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OBJECTIVES: Since pediatric growth disorders such as Growth Hormone Deﬁciency 
(GHD) and Idiopathic Short Stature (ISS) might affect subjective wellbeing and func-
tioning, treatment outcomes should include assessment of quality of life (QoL). The 
multinational QoLISSY project aims at developing simultaneously in 5 countries, a 
targeted instrument to measure outcomes in short stature children in three age groups 
(4–7, 8–12, & 13–18 yrs.). METHODS: The project follows international instrument 
development guidelines and uses focus groups, cognitive interviewing, and pilot- and 
ﬁeld testing. Per country, 24 children (height <−2 SDS) and one of their parents were 
recruited into focus groups according to age group (8–12 and 13–18 yrs.), gender, 
diagnosis (ISS/GHD) and GH-treatment (treated and non-treated). Statements derived 
from focus groups were used to formulate items which were subsequently presented to 
24 child-parent pairs per country for cognitive debrieﬁng. Additional focus groups with 
parents of very young children were also conducted. RESULTS: The focus groups 
included 96 children (age 8–18), 126 parent participants, as well as 38 parents of young 
children (4–7 yrs.). All material was transcribed and relevant passages reduced to state-
ments (1800 child, 2500 adult) which were further reduced to items (170 child, 209 
adult). CONCLUSIONS: This process provided rich material for further analysis and 
a sound basis for pilot testing. Short stature appears to be a main focus of attention for 
children and their parents, with teasing and bullying as frequent experiences. Some 
inter-individual and cross-cultural differences in concepts were found, suggesting a 
more complex model for understanding wellbeing and functioning than ﬁrst envi-
sioned. These preliminary results showed that a comprehensive taxonomy of psycho-
logical outcomes is needed as well as more research regarding the effects of psychological 
and medical treatment on quality of life of short stature children and their families.
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OBJECTIVES: Prior to use in an international study, the PedsQL™ 3.2 Diabetes 
Module consisting of 5 reports (Teen report, Adult report, Child report, Parent report 
for teens, Parent report for children) underwent linguistic validation into 10 languages. 
A rigorous methodology was conducted to ensure conceptual equivalence, cultural 
relevance and appropriateness of formulations across the 3 age categories. This 
involved forward / backward translations and testing on a sample of the 3 age groups. 
29 out of 32 items being identical in the original, the aim of our study was to inves-
tigate if this was the case in the translations, determine a potential pattern should 
there be differences and make recommendations on the basis of the results. METHODS: 
This investigation was carried out as follows: 1) Comparison of the 29 identical items 
across the Teen, Adult and Child reports in the 10 translations; 2) identiﬁcation of 
differences across the three reports; and 3) determination of a pattern in the differ-
ences. RESULTS: First results indicate that language versions are relatively similar 
across the 3 reports with few differences and no identiﬁable pattern. The differing 
formulations across age groups are not the same across translations. Differences are 
not linked to the translation of technical terms, but found in items on general symp-
toms. CONCLUSIONS: The similarities across the 3 age-speciﬁc forms for the 10 
languages seem to indicate the universal and intergenerational acceptability of the 
original concepts and their formulations. Given the differences without identiﬁable 
pattern across age categories in some languages however, it is recommended to test 
the understanding of each item through cognitive debrieﬁng on a sample of each age 
group despite the use of identical formulations in the original. This will ensure appro-
priate comprehension across age groups and translations and facilitate international 
comparison and pooling of data.
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OBJECTIVES: To examine how obesity and quality of life (QOL) affect medical (MC) 
and lost productivity costs (LPC) in U.S. adults with diabetes. METHODS: A cross 
sectional study design was applied using the 2003–2006 Medical Expenditure Panel 
Survey data. The study population consisted of patients aged 18–64 with diabetes, 
but without immunodeﬁciency, malignancy, kidney dialysis, or underweight. Diabetic 
patients’ QOL were classiﬁed as low (≤25%), medium ( > 25%- < 75%), and high 
(≥75%) based on quartiles of the SF-12 physical component scale(PCS-12) and mental 
component scale(MCS-12) respectively. Patients’ BMI was classiﬁed as normal, over-
weight, and obese. Diabetic complications included heart disease, stroke, retinopathy, 
neuropathy, and nephropathy. MCs were estimated using a generalized linear regres-
sion model with log link and gamma distribution after adjusting for patient charac-
teristics and comorbidities. LPC were calculated based on missed working days due 
to illness and average hourly wage using a two part model for working adults. All 
costs were converted to 2008 U.S. dollars. RESULTS: The study identiﬁed 3,621 
diabetic patients. Patients with low PCS-12 had more complications, compared to 
those with high PCS-12 (17.0% vs. 4.4%). A similar trend was also observed for 
MCS-12 (11.8% vs. 8.2%). In general, patients with lower PCS-12 had higher MC 
($12,203 in low-QOL vs. $3,172 in high-QOL) and LPC ($1,632 in low-QOL vs. 
$293 in high-QOL). A similar trend was found in the relationship between MCS-12 
and both costs, but this relationship was weaker than that of PCS-12. Among patients 
with medium to high PCS-12, obese patients had higher MC and LPC than normal 
or overweight patients. CONCLUSIONS: Lower levels of QOL were associated with 
a higher economic burden on diabetic patients, especially the physical QOL compo-
nent. Among diabetic patients with higher levels of physical QOL that are less con-
founded by disease severity and complications, the impact of obesity on economic 
burden was observed.
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OBJECTIVES: The objective of the study was to understand of the impact of diabetes-
related non-severe hypoglycemic episodes (NSHE’s) on work productivity and diabetes 
management. METHODS: A web-based survey was developed based on literature, 
expert input and 68 patients participating in focus-group or individual interviews. 
Persons with self-reported diabetes in US, France, Germany, and UK participated in 
the survey. NSHE’s were classiﬁed as occurring in the past month, either daytime 
(while at work or not at work) or during sleep. RESULTS: A total of 6756 persons 
were surveyed of whom 972 (14.4%) worked for pay and had a NSHE. The mean 
age of the sample was 41.3 ± 13.5. There were no signiﬁcant country differences for 
% on insulin vs. oral or % type1 vs. type 2 subjects. Fifty-nine percent of type 1 
subjects (range 50.7% in France – 70.9% in US, p = 0.001) and 34.8% of type 2 
